These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 2473898

  • 1. Synergistic induction of cytogenetic damage by alkylating antineoplastics and 5-azacytidine in human lymphocytes.
    Ioannidou E, Lialiaris T, Mourelatos D, Dozi-Vassiliades J.
    Environ Mol Mutagen; 1989; 14(1):6-12. PubMed ID: 2473898
    [Abstract] [Full Text] [Related]

  • 2. Enhancement of cytogenetic damage by chlorpromazine in human lymphocytes treated with alkylating antineoplastics and caffeine.
    Lialiaris T, Mourelatos D, Dozi-Vassiliades J.
    Mutat Res; 1988 Nov; 206(3):361-5. PubMed ID: 3200257
    [Abstract] [Full Text] [Related]

  • 3. Effects of alkylating antineoplastics alone or in combination with 3-aminobenzamide on genotoxicity, antitumor activity, and NAD levels in human lymphocytes in vitro and on Ehrlich ascites tumor cells in vivo.
    Petrou C, Mourelatos D, Mioglou E, Dozi-Vassiliades J, Catsoulacos P.
    Teratog Carcinog Mutagen; 1990 Nov; 10(4):321-31. PubMed ID: 1980034
    [Abstract] [Full Text] [Related]

  • 4. Induction of sister-chromatid exchanges and cell-cycle delays in human lymphocytes by vitamin A alone or in combination with melphalan and caffeine.
    Dozi-Vassiliades J, Myrtsiotis A, Granitsas A, Mourelatos D.
    Eur J Cancer Clin Oncol; 1985 Sep; 21(9):1089-92. PubMed ID: 4065180
    [Abstract] [Full Text] [Related]

  • 5. Enhancement of cytogenetic damage by inhibitors of poly(ADP-ribose)polymerase in human lymphocytes exposed to antineoplastics in vivo and in vitro.
    Mourelatos D, Kourakis A, Koliouskas DE, Hatzitheodoridou P, Dozi-Vassiliades J.
    Teratog Carcinog Mutagen; 1986 Sep; 6(6):485-92. PubMed ID: 2881364
    [Abstract] [Full Text] [Related]

  • 6. Synergistic induction of sister-chromatid exchanges in lymphocytes from normal subjects and from patients under cytostatic therapy by inhibitors of poly(ADP-ribose)polymerase and antitumour agents.
    Mourelatos D, Kourakis A, Dozi-Vassiliades J, Tsiouris J, Hatzitheodoridou P.
    Mutat Res; 1985 Aug; 143(4):225-30. PubMed ID: 2991758
    [Abstract] [Full Text] [Related]

  • 7. Effect of 5-azacytidine (5-azaC) on the induction of chromatid aberrations (CA) and sister-chromatid exchanges (SCE).
    Lavia P, Ferraro M, Micheli A, Olivieri G.
    Mutat Res; 1985 May; 149(3):463-7. PubMed ID: 2581131
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Dependency of the yield of sister-chromatid exchanges induced by alkylating agents on fixation time. Possible involvement of secondary lesions in sister-chromatid exchange induction.
    Kaina B, Aurich O.
    Mutat Res; 1985 May; 149(3):451-61. PubMed ID: 3990696
    [Abstract] [Full Text] [Related]

  • 14. Sister-chromatid exchanges and cell-cycle kinetics in human lymphocyte cultures exposed to alkylating mutagens: apparent deformity in dose-response relationships.
    Morimoto K, Sato-Mizuno M, Koizumi A.
    Mutat Res; 1985 May; 152(2-3):187-96. PubMed ID: 3934535
    [Abstract] [Full Text] [Related]

  • 15. Persistence of cytogenetic damage induced by alkylating antineoplastic drug phopurinum in human lymphocytes in vivo and in vitro.
    Lazutka JR, Slapsyte G.
    Cancer Lett; 1990 Nov 05; 54(3):113-8. PubMed ID: 2224839
    [Abstract] [Full Text] [Related]

  • 16. Induction of sister chromatid exchanges and cell division delays in human lymphocytes by the anti-tumour agent homo-aza-steroidal ester of p-bis(2-chloroethyl)aminophenoxy acetic acid.
    Tselepi MR, Demopoulos NA, Catsoulacos P.
    Mutagenesis; 1989 Sep 05; 4(5):361-4. PubMed ID: 2687630
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. N-Methyl-N-nitrosourea potentiation of cytogenetic damage induced by 1,3-bis(2-chloroethyl)-1-nitrosourea in normal human lymphocytes.
    Wiencke JK, Bodell WJ.
    Cancer Res; 1985 Oct 05; 45(10):4798-803. PubMed ID: 4027969
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.